LENSAR, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LNSR research report →
Companywww.lensar.com
LENSAR, Inc. , a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
- CEO
- Nicholas T. Curtis
- IPO
- 2020
- Employees
- 140
- HQ
- Orlando, FL, US
Price Chart
Valuation
- Market Cap
- $71.17M
- P/E
- 2.43
- P/S
- 1.23
- P/B
- 2.91
- EV/EBITDA
- -7.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 45.32%
- Op Margin
- -28.68%
- Net Margin
- 50.94%
- ROE
- -514.92%
- ROIC
- -33.63%
Growth & Income
- Revenue
- $58.44M · 9.24%
- Net Income
- $-34,280,000 · -9.16%
- EPS
- $-2.87 · -5.13%
- Op Income
- $-24,578,000
- FCF YoY
- -513.49%
Performance & Tape
- 52W High
- $14.03
- 52W Low
- $5.06
- 50D MA
- $6.25
- 200D MA
- $10.48
- Beta
- 0.84
- Avg Volume
- 121.10K
Get TickerSpark's AI analysis on LNSR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 6, 26 | CURTIS NICHOLAS T | other | 0 |
| May 6, 26 | Connaughton Alan B. | other | 2,739 |
| May 6, 26 | STAAB THOMAS R II | other | 1,350 |
| May 6, 26 | Wong Kendra | other | 864 |
| Mar 19, 26 | STAAB THOMAS R II | other | 5,500 |
| Mar 19, 26 | STAAB THOMAS R II | other | 5,500 |
| Feb 18, 26 | Connaughton Alan B. | other | 2,392 |
| Feb 18, 26 | STAAB THOMAS R II | other | 1,076 |
| Feb 18, 26 | CURTIS NICHOLAS T | other | 0 |
| Jan 11, 26 | CURTIS NICHOLAS T | other | 0 |
Our LNSR Coverage
We haven't published any research on LNSR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LNSR Report →